Iron oxide-loaded nanotheranostics: Major obstacles to in vivo studies and clinical translation

Journal of Controlled Release

Volumn 198, Issue , 2015, Pages 35-54

  Schleich, Nathalie ^a   Danhier, Fabienne ^a   Préat, Véronique ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

MRI; Nanomedicine; SPIO; Theranostics; Tumor targeting

Indexed keywords

HISTOLOGY; MAGNETIC RESONANCE IMAGING; MEDICAL APPLICATIONS; MEDICAL NANOTECHNOLOGY; TUMORS;

BIOMEDICAL APPLICATIONS; CLINICAL TRANSLATION; INDISPENSABLE TOOLS; PERSONALIZED THERAPIES; SPIO; SUPERPARAMAGNETIC IRON OXIDES; THERANOSTICS; TUMOR TARGETING;

IRON OXIDES;

IRON OXIDE; LIPOSOME; NANOCARRIER; NANOTHERANOSTIC; SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CONTRAST MEDIUM; FERRIC ION; FERRIC OXIDE; NANOMATERIAL;

DRUG DELIVERY SYSTEM; DRUG RELEASE; ECHOGRAPHY; FLUORESCENCE IMAGING; HUMAN; HYPERTHERMIA; IN VITRO STUDY; IN VIVO STUDY; MAGNETISM; MICELLE; MOLECULAR RECOGNITION; NANOMEDICINE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERSONALIZED MEDICINE; POSITRON EMISSION TOMOGRAPHY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ANIMAL; DIAGNOSTIC USE;

ANIMALS; ANTINEOPLASTIC AGENTS; CONTRAST MEDIA; FERRIC COMPOUNDS; HUMANS; NANOSTRUCTURES;

EID: 84916917828     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2014.11.024     Document Type: Review

References (138)

1. http://www.cancer.org/ 2014
2. Z. Fan, P.P. Fu, H. Yu, and P.C. Ray Theranostic nanomedicine for cancer detection and treatment Yao Wu Shi Pin. Fen. Xi. 22 1 2014 3 17
3. T. Lammers, F. Kiessling, W.E. Hennink, and G. Storm Nanotheranostics and image-guided drug delivery: current concepts and future directions Mol. Pharm. 7 6 2010 1899 1912
4. Y. Barenholz Doxil(R) - the first FDA-approved nano-drug: lessons learned J. Control. Release 160 2 2012 117 134
5. S. Cecco, M. Aliberti, P. Baldo, E. Giacomin, and R. Leone Safety and efficacy evaluation of albumin-bound paclitaxel Expert Opin. Drug Saf. 13 4 2014 511 520
6. C. Oerlemans, W. Bult, M. Bos, G. Storm, J.F. Nijsen, and W.E. Hennink Polymeric micelles in anticancer therapy: targeting, imaging and triggered release Pharm. Res. 27 12 2010 2569 2589
7. Y. Matsumura, and H. Maeda A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Res. 46 12 Pt 1 1986 6387 6392
8. F. Danhier, O. Feron, and V. Preat To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery J. Control. Release 148 2 2010 135 146
9. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J. Control. Release 65 1-2 2000 271 284
10. R.A. Petros, and J.M. DeSimone Strategies in the design of nanoparticles for therapeutic applications Nat. Rev. Drug Discov. 9 8 2010 615 627
11. A. Prokop, and J.M. Davidson Nanovehicular intracellular delivery systems J. Pharm. Sci. 97 9 2008 3518 3590
12. M. Wang, and M. Thanou Targeting nanoparticles to cancer Pharmacol. Res. 62 2 2010 90 99
13. R.K. Jain, and T. Stylianopoulos Delivering nanomedicine to solid tumors Nat. Rev. Clin. Oncol. 7 11 2010 653 664
14. N. Ahmed, H. Fessi, and A. Elaissari Theranostic applications of nanoparticles in cancer Drug Discov. Today 17 17-18 2012 928 934
15. J. Xie, S. Lee, and X. Chen Nanoparticle-based theranostic agents Adv. Drug Deliv. Rev. 62 11 2010 1064 1079
16. T. Lammers, S. Aime, W.E. Hennink, G. Storm, and F. Kiessling Theranostic nanomedicine Acc. Chem. Res. 44 10 2011 1029 1038
17. L.Y. Rizzo, B. Theek, G. Storm, F. Kiessling, and T. Lammers Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications Curr. Opin. Biotechnol. 24 6 2013 1159 1166
18. T. Lammers, L.Y. Rizzo, G. Storm, and F. Kiessling Personalized nanomedicine Clin. Cancer Res. 18 18 2012 4889 4894
19. F. Danhier, A. Le Breton, and V. Preat RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis Mol. Pharm. 9 11 2012 2961 2973
20. J.H. Maeng Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer 2010
21. G.R. Reddy, M.S. Bhojani, P. McConville, J. Moody, B.A. Moffat, D.E. Hall, G. Kim, Y.E. Koo, M.J. Woolliscroft, J.V. Sugai, T.D. Johnson, M.A. Philbert, R. Kopelman, A. Rehemtulla, and B.D. Ross Vascular targeted nanoparticles for imaging and treatment of brain tumors Clin. Cancer Res. 12 22 2006 6677 6686
22. J. Hu, Y. Qian, X. Wang, T. Liu, and S. Liu Drug-loaded and superparamagnetic iron oxide nanoparticle surface-embedded amphiphilic block copolymer micelles for integrated chemotherapeutic drug delivery and MR imaging Langmuir 28 4 2012 2073 2082
23. X. Yang, H. Hong, J.J. Grailer, I.J. Rowland, A. Javadi, S.A. Hurley, Y. Xiao, Y. Yang, Y. Zhang, R.J. Nickles, W. Cai, D.A. Steeber, and S. Gong cRGD-functionalized, DOX-conjugated, and (6)(4)Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging Biomaterials 32 17 2011 4151 4160
24. M. de Smet, S. Langereis, S. van den Bosch, and H. Grull Temperature-sensitive liposomes for doxorubicin delivery under MRI guidance J. Control. Release 143 1 2010 120 127
25. K.W. Hu, K.C. Hsu, and C.S. Yeh pH-Dependent biodegradable silica nanotubes derived from Gd(OH)3 nanorods and their potential for oral drug delivery and MR imaging Biomaterials 31 26 2010 6843 6848
26. A. Vaidya, Y. Sun, Y. Feng, L. Emerson, E.K. Jeong, and Z.R. Lu Contrast-enhanced MRI-guided photodynamic cancer therapy with a pegylated bifunctional polymer conjugate Pharm. Res. 25 9 2008 2002 2011
27. M. Howell, J. Mallela, C. Wang, S. Ravi, S. Dixit, U. Garapati, and S. Mohapatra Manganese-loaded lipid-micellar theranostics for simultaneous drug and gene delivery to lungs J. Control. Release 167 2 2013 210 218
28. P. Huang, L. Bao, C. Zhang, J. Lin, T. Luo, D. Yang, M. He, Z. Li, G. Gao, B. Gao, S. Fu, and D. Cui Folic acid-conjugated silica-modified gold nanorods for X-ray/CT imaging-guided dual-mode radiation and photo-thermal therapy Biomaterials 32 36 2011 9796 9809
29. J.H. Park, L. Gu, M.G. von, E. Ruoslahti, S.N. Bhatia, and M.J. Sailor Biodegradable luminescent porous silicon nanoparticles for in vivo applications Nat. Mater. 8 4 2009 331 336
30. J. Shen, H.C. Kim, H. Su, F. Wang, J. Wolfram, D. Kirui, J. Mai, C. Mu, L.N. Ji, Z.W. Mao, and H. Shen Cyclodextrin and polyethylenimine functionalized mesoporous silica nanoparticles for delivery of siRNA cancer therapeutics Theranostics 4 5 2014 487 497
31. J.H. Park, M.G. von, E. Ruoslahti, S.N. Bhatia, and M.J. Sailor Micellar hybrid nanoparticles for simultaneous magnetofluorescent imaging and drug delivery Angew. Chem. Int. Ed. Engl. 47 38 2008 7284 7288
32. R. Savla, O. Taratula, O. Garbuzenko, and T. Minko Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer J. Control. Release 153 1 2011 16 22
33. J. Yuan, W. Guo, X. Yang, and E. Wang Anticancer drug-DNA interactions measured using a photoinduced electron-transfer mechanism based on luminescent quantum dots Anal. Chem. 81 1 2009 362 368
34. S. Mukherjee, D. Chowdhury, R. Kotcherlakota, S. Patra, B. Vinothkumar, M.P. Bhadra, B. Sreedhar, and C.R. Patra Potential theranostics application of bio-synthesized silver nanoparticles (4-in-1 system) Theranostics 4 3 2014 316 335
35. Z. Gao, A.M. Kennedy, D.A. Christensen, and N.Y. Rapoport Drug-loaded nano/microbubbles for combining ultrasonography and targeted chemotherapy Ultrasonics 48 4 2008 260 270
36. K.C. Wei, P.C. Chu, H.Y. Wang, C.Y. Huang, P.Y. Chen, H.C. Tsai, Y.J. Lu, P.Y. Lee, I.C. Tseng, L.Y. Feng, P.W. Hsu, T.C. Yen, and H.L. Liu Focused ultrasound-induced blood-brain barrier opening to enhance temozolomide delivery for glioblastoma treatment: a preclinical study PLoS One 8 3 2013 e58995
37. Z. Liu, K. Chen, C. Davis, S. Sherlock, Q. Cao, X. Chen, and H. Dai Drug delivery with carbon nanotubes for in vivo cancer treatment Cancer Res. 68 16 2008 6652 6660
38. J.T. Robinson, K. Welsher, S.M. Tabakman, S.P. Sherlock, H. Wang, R. Luong, and H. Dai High performance in vivo near-IR (> 1 mum) imaging and photothermal cancer therapy with carbon nanotubes Nano Res. 3 11 2010 779 793
39. A. Mitra, A. Nan, H. Ghandehari, E. McNeill, J. Mulholland, and B.R. Line Technetium-99 m-labeled N-(2-hydroxypropyl) methacrylamide copolymers: synthesis, characterization, and in vivo biodistribution Pharm. Res. 21 7 2004 1153 1159
40. C. Corot, and D. Warlin Superparamagnetic iron oxide nanoparticles for MRI: contrast media pharmaceutical company R&D perspective Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 5 5 2013 411 422
41. S. Laurent, and M. Mahmoudi Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of cancer Int. J. Mol. Epidemiol. Genet. 2 4 2011 367 390
42. S. Laurent, A.A. Saei, S. Behzadi, A. Panahifar, and M. Mahmoudi Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges Expert Opin. Drug Deliv. 1-22 2014
43. L.H. Reddy, J.L. Arias, J. Nicolas, and P. Couvreur Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications Chem. Rev. 112 11 2012 5818 5878
44. P.B. Santhosh, and N.P. Ulrih Multifunctional superparamagnetic iron oxide nanoparticles: promising tools in cancer theranostics Cancer Lett. 336 1 2013 8 17
45. J.E. Rosen, L. Chan, D.B. Shieh, and F.X. Gu Iron oxide nanoparticles for targeted cancer imaging and diagnostics Nanomedicine 8 3 2012 275 290
46. T. Yu, D. Hubbard, A. Ray, and H. Ghandehari In vivo biodistribution and pharmacokinetics of silica nanoparticles as a function of geometry, porosity and surface characteristics J. Control. Release 163 1 2012 46 54
47. H. Ittrich, K. Peldschus, N. Raabe, M. Kaul, and G. Adam Superparamagnetic iron oxide nanoparticles in biomedicine: applications and developments in diagnostics and therapy Röfo 185 12 2013 1149 1166
48. J.T. Ferrucci, and D.D. Stark Iron oxide-enhanced MR imaging of the liver and spleen: review of the first 5 years AJR Am. J. Roentgenol. 155 5 1990 943 950
49. P. Zou, Y. Yu, Y.A. Wang, Y. Zhong, A. Welton, C. Galban, S. Wang, and D. Sun Superparamagnetic iron oxide nanotheranostics for targeted cancer cell imaging and pH-dependent intracellular drug release Mol. Pharm. 7 6 2010 1974 1984
50. Wahajuddin S. Arora Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers Int. J. Nanomedicine 7 2012 3445 3471
51. P.C. Brooks, R.A. Clark, and D.A. Cheresh Requirement of vascular integrin alpha v beta 3 for angiogenesis Science 264 5158 1994 569 571
52. J.L. Arias Drug targeting strategies in cancer treatment: an overview Mini-Rev. Med. Chem. 11 1 2011 1 17
53. T. Lammers, W.E. Hennink, and G. Storm Tumour-targeted nanomedicines: principles and practice Br. J. Cancer 99 3 2008 392 397
54. V.P. Torchilin Targeted polymeric micelles for delivery of poorly soluble drugs Cell. Mol. Life Sci. 61 19-20 2004 2549 2559
55. X.H. Peng, X. Qian, H. Mao, A.Y. Wang, Z.G. Chen, S. Nie, and D.M. Shin Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy Int. J. Nanomedicine 3 3 2008 311 321
56. N. Schleich, P. Sibret, P. Danhier, B. Ucakar, S. Laurent, R.N. Muller, C. Jerome, B. Gallez, V. Preat, and F. Danhier Dual anticancer drug/superparamagnetic iron oxide-loaded PLGA-based nanoparticles for cancer therapy and magnetic resonance imaging Int. J. Pharm. 447 1-2 2013 94 101
57. Y. Ling, K. Wei, Y. Luo, X. Gao, and S. Zhong Dual docetaxel/superparamagnetic iron oxide loaded nanoparticles for both targeting magnetic resonance imaging and cancer therapy Biomaterials 32 29 2011 7139 7150
58. Y. Ling, K. Wei, F. Zou, and S. Zhong Temozolomide loaded PLGA-based superparamagnetic nanoparticles for magnetic resonance imaging and treatment of malignant glioma Int. J. Pharm. 430 1-2 2012 266 275
59. W. Chen, N. Xu, L. Xu, L. Wang, Z. Li, W. Ma, Y. Zhu, C. Xu, and N.A. Kotov Multifunctional magnetoplasmonic nanoparticle assemblies for cancer therapy and diagnostics (theranostics) Macromol. Rapid Commun. 31 2 2010 228 236
60. J. Kim, H.S. Kim, N. Lee, T. Kim, H. Kim, T. Yu, I.C. Song, W.K. Moon, and T. Hyeon Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery Angew. Chem. Int. Ed. Engl. 47 44 2008 8438 8441
61. N. Kohler, C. Sun, A. Fichtenholtz, J. Gunn, C. Fang, and M. Zhang Methotrexate-immobilized poly(ethylene glycol) magnetic nanoparticles for MR imaging and drug delivery Small 2 6 2006 785 792
62. I.K. Park, C.P. Ng, J. Wang, B. Chu, C. Yuan, S. Zhang, and S.H. Pun Determination of nanoparticle vehicle unpackaging by MR imaging of a T(2) magnetic relaxation switch Biomaterials 29 6 2008 724 732
63. Y.H. Baek, and Park Targeted drug delivery to tumors: myths, reality and possibility J. Control. Release 153 3 2011 198 205
64. H. Maeda Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumor-selective drug targeting Proc Jpn. Acad Ser. B Phys. Biol. Sci. 88 3 2012 53 71
65. J.W. Nichols, and Y.H. Bae Odyssey of a cancer nanoparticle: from injection site to site of action Nano Today 7 6 2012 606 618
66. M. Kumagai, M.R. Kano, Y. Morishita, M. Ota, Y. Imai, N. Nishiyama, M. Sekino, S. Ueno, K. Miyazono, and K. Kataoka Enhanced magnetic resonance imaging of experimental pancreatic tumor in vivo by block copolymer-coated magnetite nanoparticles with TGF-beta inhibitor J. Control. Release 140 3 2009 306 311
67. T.D. McKee, P. Grandi, W. Mok, G. Alexandrakis, N. Insin, J.P. Zimmer, M.G. Bawendi, Y. Boucher, X.O. Breakefield, and R.K. Jain Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vector Cancer Res. 66 5 2006 2509 2513
68. A.J. Cole, V.C. Yang, and A.E. David Cancer theranostics: the rise of targeted magnetic nanoparticles Trends Biotechnol. 29 7 2011 323 332
69. S.S. Kelkar, and T.M. Reineke Theranostics: combining imaging and therapy Bioconjug. Chem. 22 10 2011 1879 1903
70. J. Folkman Tumor angiogenesis: therapeutic implications N. Engl. J. Med. 285 21 1971 1182 1186
71. G. Hong, R. Yuan, B. Liang, J. Shen, X. Yang, and X. Shuai Folate-functionalized polymeric micelle as hepatic carcinoma-targeted, MRI-ultrasensitive delivery system of antitumor drugs Biomed. Microdevices 10 5 2008 693 700
72. X. Yang, J.J. Grailer, I.J. Rowland, A. Javadi, S.A. Hurley, D.A. Steeber, and S. Gong Multifunctional SPIO/DOX-loaded wormlike polymer vesicles for cancer therapy and MR imaging Biomaterials 31 34 2010 9065 9073
73. M. Liong, J. Lu, M. Kovochich, T. Xia, S.G. Ruehm, A.E. Nel, F. Tamanoi, and J.I. Zink Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery ACS Nano 2 5 2008 889 896
74. N. Kohler, C. Sun, J. Wang, and M. Zhang Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells Langmuir 21 19 2005 8858 8864
75. N. Nasongkla, E. Bey, J. Ren, H. Ai, C. Khemtong, J.S. Guthi, S.F. Chin, A.D. Sherry, D.A. Boothman, and J. Gao Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems Nano Lett. 6 11 2006 2427 2430
76. A.H. Schmieder, S.D. Caruthers, H. Zhang, T.A. Williams, J.D. Robertson, S.A. Wickline, and G.M. Lanza Three-dimensional MR mapping of angiogenesis with alpha5beta1(alpha nu beta3)-targeted theranostic nanoparticles in the MDA-MB-435 xenograft mouse model FASEB J. 22 12 2008 4179 4189
77. J.S. Guthi, S.G. Yang, G. Huang, S. Li, C. Khemtong, C.W. Kessinger, M. Peyton, J.D. Minna, K.C. Brown, and J. Gao MRI-visible micellar nanomedicine for targeted drug delivery to lung cancer cells Mol. Pharm. 7 1 2010 32 40
78. L. Shan Polyethylene Glycol-coated and Folic acid-conjugated Superparamagnetic Iron Oxide Nanoparticles 2004
79. K. Temming, R.M. Schiffelers, G. Molema, and R.J. Kok RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature Drug Resist. Updat. 8 6 2005 381 402
80. I.K. Kwon, S.C. Lee, B. Han, and K. Park Analysis on the current status of targeted drug delivery to tumors J. Control. Release 164 2 2012 108 114
81. P. Kocbek, S. Kralj, M.E. Kreft, and J. Kristl Targeting intracellular compartments by magnetic polymeric nanoparticles Eur. J. Pharm. Sci. 50 1 2013 130 138
82. A. Kumari, and S.K. Yadav Cellular interactions of therapeutically delivered nanoparticles Expert Opin. Drug Deliv. 8 2 2011 141 151
83. R. Duncan, and R. Gaspar Nanomedicine(s) under the microscope Mol. Pharm. 8 6 2011 2101 2141
84. R. van der Meel, L.J. Vehmeijer, R.J. Kok, G. Storm, and E.V. van Gaal Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status Adv. Drug Deliv. Rev. 65 10 2013 1284 1298
85. K.Y. Kim Nanotechnology platforms and physiological challenges for cancer therapeutics Nanomedicine 3 2 2007 103 110
86. S.P. Egusquiaguirre, M. Igartua, R.M. Hernandez, and J.L. Pedraz Nanoparticle delivery systems for cancer therapy: advances in clinical and preclinical research Clin. Transl. Oncol. 14 2 2012 83 93
87. S.T. Feng, J. Li, Y. Luo, T. Yin, H. Cai, Y. Wang, Z. Dong, X. Shuai, and Z.P. Li pH-sensitive nanomicelles for controlled and efficient drug delivery to human colorectal carcinoma LoVo cells PLoS One 9 6 2014 e100732
88. X. Li, H. Li, W. Yi, J. Chen, and B. Liang Acid-triggered core cross-linked nanomicelles for targeted drug delivery and magnetic resonance imaging in liver cancer cells Int. J. Nanomedicine 8 2013 3019 3031
89. M.M. Yallapu, S.F. Othman, E.T. Curtis, B.K. Gupta, M. Jaggi, and S.C. Chauhan Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapy Biomaterials 32 7 2011 1890 1905
90. G. Baldi, C. Ravagli, F. Mazzantini, G. Loudos, J. Adan, M. Masa, D. Psimadas, E.A. Fragogeorgi, E. Locatelli, C. Innocenti, C. Sangregorio, and F.M. Comes In vivo anticancer evaluation of the hyperthermic efficacy of anti-human epidermal growth factor receptor-targeted PEG-based nanocarrier containing magnetic nanoparticles Int. J. Nanomedicine 9 2014 3037 3056
91. Y. Yang, K. Yu, H. Zhang, J. Dai, and Z. Deng In vitro assessment of the dual-targeting behavior of a peptide-based magnetic resonance imaging contrast agent Int. J. Mol. Med. 33 1 2014 215 220
92. J.L. Arias, L.H. Reddy, M. Othman, B. Gillet, D. Desmaele, F. Zouhiri, F. Dosio, R. Gref, and P. Couvreur Squalene based nanocomposites: a new platform for the design of multifunctional pharmaceutical theragnostics ACS Nano 5 2 2011 1513 1521
93. H.W. Yang, M.Y. Hua, H.L. Liu, R.Y. Tsai, S.T. Pang, P.H. Hsu, H.J. Tang, T.C. Yen, and C.K. Chuang An epirubicin-conjugated nanocarrier with MRI function to overcome lethal multidrug-resistant bladder cancer Biomaterials 33 15 2012 3919 3930
94. C. Alexiou, W. Arnold, R.J. Klein, F.G. Parak, P. Hulin, C. Bergemann, W. Erhardt, S. Wagenpfeil, and A.S. Lubbe Locoregional cancer treatment with magnetic drug targeting Cancer Res. 60 23 2000 6641 6648
95. E. Gullotti, and Y. Yeo Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery Mol. Pharm. 6 4 2009 1041 1051
96. H. Wu, L. Zhu, and V.P. Torchilin pH-sensitive poly(histidine)-PEG/DSPE-PEG co-polymer micelles for cytosolic drug delivery Biomaterials 34 4 2013 1213 1222
97. M. Johannsen, U. Gneveckow, L. Eckelt, A. Feussner, N. Waldofner, R. Scholz, S. Deger, P. Wust, S.A. Loening, and A. Jordan Clinical hyperthermia of prostate cancer using magnetic nanoparticles: presentation of a new interstitial technique Int. J. Hyperthermia 21 7 2005 637 647
98. K. Maier-Hauff, F. Ulrich, D. Nestler, H. Niehoff, P. Wust, B. Thiesen, H. Orawa, V. Budach, and A. Jordan Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme J. Neurooncol. 103 2 2011 317 324
99. A. Singh, and S.K. Sahoo Magnetic nanoparticles: a novel platform for cancer theranostics Drug Discov. Today 19 4 2014 474 481
100. G. Malietzis, L. Monzon, J. Hand, H. Wasan, E. Leen, M. Abel, A. Muhammad, P. Price, and P. Abel High-intensity focused ultrasound: advances in technology and experimental trials support enhanced utility of focused ultrasound surgery in oncology Br. J. Radiol. 86 1024 2013 20130044
101. S.A. Abouelmagd, H. Hyun, and Y. Yeo Extracellularly activatable nanocarriers for drug delivery to tumors Expert Opin. Drug Deliv. 1-18 2014
102. A. Yudina, and C. Moonen Ultrasound-induced cell permeabilisation and hyperthermia: strategies for local delivery of compounds with intracellular mode of action Int. J. Hyperthermia 28 4 2012 311 319
103. P.S. Yang, F.I. Tung, H.P. Chen, T.Y. Liu, and Y.Y. Lin A novel bubble-forming material for preparing hydrophobic-agent-loaded bubbles with theranostic functionality Acta Biomater. 10 8 2014 3762 3774
104. S. Ibsen, C.E. Schutt, and S. Esener Microbubble-mediated ultrasound therapy: a review of its potential in cancer treatment Drug Des. Dev. Ther. 7 2013 375 388
105. S. Mo, C.C. Coussios, L. Seymour, and R. Carlisle Ultrasound-enhanced drug delivery for cancer Expert Opin. Drug Deliv. 9 12 2012 1525 1538
106. A.S. Lubbe, C. Bergemann, W. Huhnt, T. Fricke, H. Riess, J.W. Brock, and D. Huhn Preclinical experiences with magnetic drug targeting: tolerance and efficacy Cancer Res. 56 20 1996 4694 4701
107. H.Y. Huang, Y.T. Shieh, C.M. Shih, and Y.K. Twu Magnetic chitosan/iron (II, III) oxide nanoparticles prepared by spray-drying Carbohydr. Polym. 81 4 2010 906 910
108. J. Riegler, J.A. Wells, P.G. Kyrtatos, A.N. Price, Q.A. Pankhurst, and M.F. Lythgoe Targeted magnetic delivery and tracking of cells using a magnetic resonance imaging system Biomaterials 31 20 2010 5366 5371
109. B. Polyak, I. Fishbein, M. Chorny, I. Alferiev, D. Williams, B. Yellen, G. Friedman, and R.J. Levy High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents Proc. Natl. Acad. Sci. U. S. A. 105 2 2008 698 703
110. P. Pradhan, J. Giri, F. Rieken, C. Koch, O. Mykhaylyk, M. Doblinger, R. Banerjee, D. Bahadur, and C. Plank Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy J. Control. Release 142 1 2010 108 121
111. C.H. Fan, C.Y. Ting, H.J. Lin, C.H. Wang, H.L. Liu, T.C. Yen, and C.K. Yeh SPIO-conjugated, doxorubicin-loaded microbubbles for concurrent MRI and focused-ultrasound enhanced brain-tumor drug delivery Biomaterials 34 14 2013 3706 3715
112. N. Schleich, C. Po, D. Jacobs, B. Ucakar, B. Gallez, F. Danhier, and V. Préat Comparison of active, passive and magnetic targeting to tumors of multifunctional paclitaxel/SPIO-loaded nanoparticles for tumor imaging and therapy J. Control. Release 194 2014 82 91
113. Z. Li, C. Wang, L. Cheng, H. Gong, S. Yin, Q. Gong, Y. Li, and Z. Liu PEG-functionalized iron oxide nanoclusters loaded with chlorin e6 for targeted, NIR light induced, photodynamic therapy Biomaterials 34 36 2013 9160 9170
114. M.P. Melancon, W. Lu, M. Zhong, M. Zhou, G. Liang, A.M. Elliott, J.D. Hazle, J.N. Myers, C. Li, and R.J. Stafford Targeted multifunctional gold-based nanoshells for magnetic resonance-guided laser ablation of head and neck cancer Biomaterials 32 30 2011 7600 7608
115. B. Moses, and Y. You Emerging strategies for controlling drug release by using visible/near IR light Med. Chem. 3 2 2013 192 198
116. D. Wang, B. Fei, L.V. Halig, X. Qin, Z. Hu, H. Xu, Y.A. Wang, Z. Chen, S. Kim, D.M. Shin, and Z.G. Chen Targeted iron-oxide nanoparticle for photodynamic therapy and imaging of head and neck cancer ACS Nano 8 7 2014 6620 6632
117. H.J. Nyst, I.B. Tan, F.A. Stewart, and A.J. Balm Is photodynamic therapy a good alternative to surgery and radiotherapy in the treatment of head and neck cancer? Photodiagn. Photodyn. Ther. 6 1 2009 3 11
118. D.K. Chatterjee, L.S. Fong, and Y. Zhang Nanoparticles in photodynamic therapy: an emerging paradigm Adv. Drug Deliv. Rev. 60 15 2008 1627 1637
119. W. Jerjes, Z. Hamdoon, and C. Hopper Photodynamic therapy in the management of potentially malignant and malignant oral disorders Head Neck Oncol. 4 2012 16
120. Y. Cohen, and S.Y. Shoushan Magnetic nanoparticles-based diagnostics and theranostics Curr. Opin. Biotechnol. 24 4 2013 672 681
121. S. Mura, and P. Couvreur Nanotheranostics for personalized medicine Adv. Drug Deliv. Rev. 64 13 2012 1394 1416
122. J. Lu, S. Ma, J. Sun, C. Xia, C. Liu, Z. Wang, X. Zhao, F. Gao, Q. Gong, B. Song, X. Shuai, H. Ai, and Z. Gu Manganese ferrite nanoparticle micellar nanocomposites as MRI contrast agent for liver imaging Biomaterials 30 15 2009 2919 2928
123. J.E. Bae, M.I. Huh, B.K. Ryu, J.Y. Do, S.U. Jin, M.J. Moon, J.C. Jung, Y. Chang, E. Kim, S.G. Chi, G.H. Lee, and K.S. Chae The effect of static magnetic fields on the aggregation and cytotoxicity of magnetic nanoparticles Biomaterials 32 35 2011 9401 9414
124. W.J. Yang, J.H. Lee, S.C. Hong, J. Lee, J. Lee, and D. Han Difference between toxicities of iron oxide magnetic nanoparticles with various surface functional groups against human normal fibroblasts and fibrosarcoma cells Materials 6 10 2013 4689 4706
125. T.K. Jain, M.K. Reddy, M.A. Morales, D.L. Leslie-Pelecky, and V. Labhasetwar Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats Mol. Pharm. 5 2 2008 316 327
126. D. Peer, J.M. Karp, S. Hong, O.C. Farokhzad, R. Margalit, and R. Langer Nanocarriers as an emerging platform for cancer therapy Nat. Nanotechnol. 2 12 2007 751 760
127. T. Lammers, F. Kiessling, W.E. Hennink, and G. Storm Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress J. Control. Release 161 2 2012 175 187
128. M. Wacker Nanocarriers for intravenous injection - the long hard road to the market Int. J. Pharm. 457 1 2013 50 62
129. S. Svenson Theranostics: are we there yet? Mol. Pharm. 10 3 2013 848 856
130. L.W. Seymour, D.R. Ferry, D. Anderson, S. Hesslewood, P.J. Julyan, R. Poyner, J. Doran, A.M. Young, S. Burtles, and D.J. Kerr Hepatic drug targeting: phase I evaluation of polymer-bound doxorubicin J. Clin. Oncol. 20 6 2002 1668 1676
131. K.J. Harrington, S. Mohammadtaghi, P.S. Uster, D. Glass, A.M. Peters, R.G. Vile, and J.S. Stewart Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes Clin. Cancer Res. 7 2 2001 243 254
132. F. Kiessling, S. Fokong, P. Koczera, W. Lederle, and T. Lammers Ultrasound microbubbles for molecular diagnosis, therapy, and theranostics J. Nucl. Med. 53 3 2012 345 348
133. M. Kalia Personalized oncology: recent advances and future challenges Metabolism 62 Suppl. 1 2013 S11 S14
134. S. Zitzmann, V. Ehemann, and M. Schwab Arginine-glycine-aspartic acid (RGD)-peptide binds to both tumor and tumor-endothelial cells in vivo Cancer Res. 62 18 2002 5139 5143
135. T.R. Daniels, T. Delgado, J.A. Rodriguez, G. Helguera, and M.L. Penichet The transferrin receptor part I: biology and targeting with cytotoxic antibodies for the treatment of cancer Clin. Immunol. 121 2 2006 144 158
136. T.R. Daniels, T. Delgado, G. Helguera, and M.L. Penichet The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells Clin. Immunol. 121 2 2006 159 176
137. R.T. Tong, Y. Boucher, S.V. Kozin, F. Winkler, D.J. Hicklin, and R.K. Jain Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors Cancer Res. 64 2004 3731 3736
138. Y. Zhong, F. Meng, C. Deng, and Z. Zhong Ligand-directed active tumor-targeting polymeric nanoparticles for cancer chemotherapy Biomacromolecules 15 6 2014 1955 1969